Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis.

Am J Trop Med Hyg. 1999 Apr;60(4):680-6. Unique Identifier : AIDSLINE MED/99276004
Winkler S; Willheim M; Baier K; Aichelburg A; Kremsner PG; Graninger W; Department of Internal Medicine I, and Institute of General and; Experimental Pathology, University of Vienna, Austria.


Abstract: The frequency of cytokine-producing peripheral blood mononuclear cells was assessed in 28 subjects with microfilaremic loiasis and in 14 amicrofilaremic individuals. In addition, a subgroup of seven microfilaremic individuals coinfected with Plasmodium malariae was evaluated. By using flow cytometry for the intracellular detection of cytokines, a more pronounced T helper (Th)2 cell-type response with the expansion of interleukin (IL)-4, IL-10, and IL-13 expressing CD4+ cells in the microfilaremic compared with the amicrofilaremic group was noted. Expression of IL-5 was equivalent in both groups as was the frequency of Th2-type cytokines expressing CD8+ cells and of Th1-type cytokines (interferon [IFN]-gamma, IL-2, IFN-gamma/IL-2) producing CD4+ and CD8+ cells. Th0-type cytokine-expressing cells, represented by IL-4/IFN-gamma, IL-10/IFN-gamma, and IL-13/IFN-gamma, were equally distributed within groups. Coinfection of P. malariae did not significantly alter the cytokine expression compared with microfilaremic individuals without P. malariae infections. By identifying a large panel of cytokine-producing T cell subpopulations, a Th2-driven immune response in microfilaremic Loa loa patients was noted.
Keywords: JOURNAL ARTICLE Adult Aged Aged, 80 and over Animal Cytokines/*BIOSYNTHESIS CD4-Positive T-Lymphocytes/IMMUNOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY Female Flow Cytometry Human Loa/IMMUNOLOGY Loiasis/COMPLICATIONS/*IMMUNOLOGY Malaria/COMPLICATIONS/IMMUNOLOGY Male Microfilaria/IMMUNOLOGY Middle Age Parasitemia/IMMUNOLOGY Plasmodium malariae/IMMUNOLOGY Support, Non-U.S. Gov't Th2 Cells/*IMMUNOLOGYKWDjournalarticleadultagedaged,80andoveranimalcytokines/KWDbiosynthesiscd4-positivet-lymphocytes/immunologycd8-positivet-lymphocytes/immunologyfemaleflowcytometryhumanloa/immunologyloiasis/complications/KWDimmunologymalaria/complications/immunologymalemicrofilaria/immunologymiddleageparasitemia/immunologyplasmodiummalariae/immunologysupport,non-uKWDsKWDgov'tth2cells/KWDimmunology
990830
A9980467

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .